Meissa Vaccines' Grant

Meissa Vaccines raised a round of funding on May 10, 2017. Investors include National Institutes of Health.

Meissa Vaccines is a start-up pharmaceutical development company focused on the in-licensing and advancement of vaccines for respiratory syncytial virus (RSV, the largest unmet respiratory medical nee…

Articles about Meissa Vaccines' Grant: